GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ocumetics Technology Corp (TSXV:OTC) » Definitions » Debt-to-EBITDA

Ocumetics Technology (TSXV:OTC) Debt-to-EBITDA : -0.12 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Ocumetics Technology Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ocumetics Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.00 Mil. Ocumetics Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$0.32 Mil. Ocumetics Technology's annualized EBITDA for the quarter that ended in Dec. 2023 was C$-2.71 Mil. Ocumetics Technology's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.12.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ocumetics Technology's Debt-to-EBITDA or its related term are showing as below:

TSXV:OTC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.14   Med: -0.12   Max: -0.09
Current: -0.09

During the past 4 years, the highest Debt-to-EBITDA Ratio of Ocumetics Technology was -0.09. The lowest was -0.14. And the median was -0.12.

TSXV:OTC's Debt-to-EBITDA is ranked worse than
100% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.25 vs TSXV:OTC: -0.09

Ocumetics Technology Debt-to-EBITDA Historical Data

The historical data trend for Ocumetics Technology's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumetics Technology Debt-to-EBITDA Chart

Ocumetics Technology Annual Data
Trend Jul20 Jul21 Dec22 Dec23
Debt-to-EBITDA
- - -0.14 -0.09

Ocumetics Technology Quarterly Data
Jul20 Jul21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.15 - - - -0.12

Competitive Comparison of Ocumetics Technology's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Ocumetics Technology's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocumetics Technology's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ocumetics Technology's Debt-to-EBITDA falls into.



Ocumetics Technology Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ocumetics Technology's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0.322) / -3.497
=-0.09

Ocumetics Technology's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0.322) / -2.708
=-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Ocumetics Technology  (TSXV:OTC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ocumetics Technology Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ocumetics Technology's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocumetics Technology (TSXV:OTC) Business Description

Traded in Other Exchanges
Address
639 - 5th Avenue S.W., Suite 1250, Calgary, AB, CAN, T2P 0M9
Ocumetics Technology Corp is a Canadian-based research and product development company. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses, especially for people over 45 years of age.
Executives
Roger Jewett Director, Senior Officer

Ocumetics Technology (TSXV:OTC) Headlines

No Headlines